Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer
NCT05475847
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Cervical Cancer
Interventions
BIOLOGICAL:
Autologous Tumor Infiltrating Lymphocytes (C-TIL052A) Injection
Sponsor
Fudan University
Collaborators
[object Object]